PMGC Holdings Inc. (NASDAQ:ELAB – Free Report)’s stock is set to reverse split on Tuesday, March 10th. The 1-6 reverse split was announced on Wednesday, March 4th. The number of shares owned by shareholders will be adjusted after the market closes on Monday, March 9th.
PMGC Price Performance
NASDAQ:ELAB opened at $0.71 on Friday. The firm has a market cap of $2.29 million, a price-to-earnings ratio of -0.01 and a beta of 1.12. The firm’s fifty day moving average price is $3.06 and its 200 day moving average price is $14.84. PMGC has a 1-year low of $0.68 and a 1-year high of $114.38.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of PMGC in a report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.
About PMGC
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.
Read More
- Five stocks we like better than PMGC
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for PMGC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMGC and related companies with MarketBeat.com's FREE daily email newsletter.
